(Rac)-Vazegepant-13C,d3

Product Description: (Rac)-Vazegepant-13C,d3 is the C13 and deuterium labeled (Rac)-Vazegepant. Vazegepant (HY-134992) is the first intranasal CGRP receptor antagonist for the study the acute research of migraine[1][2].

Formula: C35 13CH43D3N8O3

References: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216./[2]Leonard KA, et al. Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel Disease. J Med Chem. 2020 Mar 26;63(6):2915-2929.

Molecular Weight: 642.81

Research Area: Others

Solubility: 10 mM in DMSO

Target: Isotope-Labeled Compounds

• SKU: MEXHY-134992S-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-134992S-1
• Package Unit: 1 mg
• Quantity Unit: STK